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Background/aim: The aim of this study was to determine mortality rates and to evaluate clinical features of patients with active
tuberculosis (TB) requiring intensive care unit (ICU) admission.
Materials and methods: The medical records of active TB patients requiring ICU admission were retrospectively reviewed over a 5-year
period.
Results: Sixteen patients with active TB admitted to the ICU were included in the study. Seven (43.8%) patients died in the ICU.
The cause of mortality was septic shock in 5 patients and respiratory failure in 2 patients. The Acute Physiology and Chronic Health
Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores were higher in patients who died (P = 0.012 and
0.048, respectively). Six of the 8 immunosuppressed patients and 1 of the 8 nonimmunosuppressed patients died (P = 0.041). The
median mechanical ventilation (MV) duration was longer in patients who died (11 (5–45) days) than in patients who survived (4.5 (3–7)
days) (P = 0.036). Seven of the 8 patients with nosocomial infection and/or coinfection died, while all of the patients without additional
infection survived (P = 0.01).
Conclusion: Active TB patients admitted to the ICU had higher mortality rates, especially patients with immunosuppression, nosocomial
infection, high APACHE II and SOFA scores, and patients receiving MV.
Key words: Acute disease, tuberculosis, intensive care, critical illness, sepsis

1. Introduction
Tuberculosis (TB) is a disease that can affect almost all
organs of the body, particularly the lungs. Postprimary
pulmonary TB is the most common type in adults, but the
disease may present with different clinical and radiological
features, especially in areas where tuberculosis is highly
prevalent. TB is known as a chronic infectious disease, but
it can mimic other infectious or noninfectious processes
and may present acutely. The most common forms of TB
presenting acutely are pulmonary, miliary, and meningeal
(1). Pulmonary and miliary TB can lead to acute
hypoxemic respiratory failure and, rarely, acute respiratory
distress syndrome (2,3). Central nervous system TB,
particularly meningoencephalitis, is the most severe form
of extrapulmonary TB (4). This form of TB can cause
impaired levels of consciousness including confusion,
stupor, and coma. Delays in diagnosis and appropriate
treatment may cause death in all these acute forms of TB.
Mortality rates of active TB patients with acute
respiratory failure requiring mechanical ventilation (MV)
range between 17.5% and 81% (2,5–8). The frequency
* Correspondence: atopeli@hacettepe.edu.tr
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of intensive care unit (ICU) admission in patients with
TB ranges between 1% and 3% (2,7,8). These patients
often have pulmonary TB or miliary TB with serious
comorbidities.
Several studies have attempted to identify clinical
features of active TB requiring ICU admission (5,8–11).
Most of them focused on pulmonary TB requiring
mechanical ventilation. The aim of this study was to
determine mortality rates and evaluate clinical features of
newly diagnosed TB patients requiring ICU admission.
We distinguished acute presentation of newly diagnosed
TB from patients who had previous TB and/or who had
already been receiving anti-TB medications for at least 30
days before admission.
2. Materials and methods
2.1. Patients
We retrospectively reviewed the records of all patients
admitted to the 9-bed medical ICU of a university
hospital between 1 January 2009 and 1 January 2014
with a diagnosis of active TB. Only “new case of TB”
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patients were included (World Health Organization.
Global tuberculosis report 2013, Geneva (2013)). Patients
with clinical and radiological features of TB and positive
cultures or positive acid-fast bacilli smears of biologic fluid
specimens (sputum, bronchial aspirates, bronchoalveolar
lavage, cerebrospinal, pleural, peritoneal fluids), and/or
biopsy-proven caseating granuloma consistent with TB
were included. Patients who had already been receiving
anti-TB medications at least 30 days before ICU admission
were excluded.
Clinical data were obtained from medical and
radiological imaging records. These data included age,
sex, Acute Physiology and Chronic Health Evaluation
(APACHE) II scores, Sequential Organ Failure Assessment
(SOFA) scores, Glasgow Coma Scores (GCS), organs
affected by TB, comorbidities, nosocomial infections and/
or coinfections, medications, duration of mechanical
ventilation, time from symptom onset to treatment,
duration of hospital and ICU stay, radiographic findings
of the lung, laboratory tests (blood chemistry and
complete blood count), acid fast bacilli smear and culture
results, and drug sensitivity of mycobacterium tuberculosis
isolates. The study was approved by the Ethics Committee
of Hacettepe University (no: 16969557-425).
2.2. Definitions
A new case of TB was defined as “a patient who has never
taken medication for TB or has taken anti-TB drugs for
less than 1 month”, based on World Health Organization
definitions (World Health Organization. Global
tuberculosis report 2013, Geneva (2013). http://www.
who.int/tb/publications/global_report/en/index.html.
Accessed: 23 October 2013.). TB cases were classified as
pulmonary TB, extrapulmonary TB, and pulmonary plus
extrapulmonary TB. Pulmonary TB was defined as a TB
disease involving the lung parenchyma. Extrapulmonary
TB was defined as TB of organs other than the lungs.
Miliary tuberculosis was defined as TB with disseminated
micronodules on the chest X-ray.
Immunodeficiency was defined when any of the
following was present: human immunodeficiency virus
(HIV) infection, underlying hematological cancer; steroid
use (>1 mg/kg per day), or other immunosuppressive
therapy for at least 1 month. Radiographic patterns were
classified as cavity, miliary, consolidation, nodular, and
pleural effusion. Sepsis syndromes were defined according
to the latest survival sepsis guideline (12).
2.3. Statistical analysis
Data analysis was performed using SPSS 15.0 (Statistical
Package for the Social Sciences, USA). Data were presented
as number of cases, percentage, and median (minimum
and maximum). Categorical comparisons were performed
by chi-square test. The Mann–Whitney U test was applied
to compare continuous variables. A P value <0.05 was
considered statistically significant.

3. Results
During the 5-year period, 23 active TB patients were
admitted to our intensive care unit. One patient died
within 24 h after ICU admission, and 6 patients had already
been receiving anti-TB drugs for more than 1 month. After
these patients were excluded, 16 active TB patients were
included in the study.
The characteristics and clinical features of all patients
are shown in Table 1. The median age of the patients was 45
(24–74) years. Nine of the patients were male and 7 were
female. The median APACHE II score was 21.5 (6–36) and
the median SOFA score was 6 (1–12). Of the 16 patients,
3 had pulmonary, 3 had extrapulmonary, 4 had both
pulmonary and extrapulmonary, and 6 had miliary TB.
Extrapulmonary TB sites included meningoencephalitis
(based on radiological features of TB meningoencephalitis
and positive cultures or positive acid-fast bacilli smears
of cerebrospinal fluid) in 4 patients, pleura in 1 patient
(based on positive culture), the intestine in 1 (based on
biopsy-proven caseating granuloma consistent with TB),
and lymphadenopathy (based on biopsy-proven caseating
granuloma consistent with TB and positive cultures or
positive acid-fast bacilli smears) in 1 patient. Comorbidities
were not present in 5 patients and 2 patients were positive
for HIV infection. Eight (50%) patients had a history of
immunosuppression due to drug or underlying disease.
Ten (62.5%) patients received MV. Eight (50%) patients
had nosocomial and/or coinfection including bacteremia,
meningitis, and ventilator associated pneumonia. The
primary cause for ICU admission was acute respiratory
failure in 5 (31.3%), sepsis in 5 (31.3%), neurological
deterioration in 5 (31.3%), and hemoptysis in 1 (6.3%).
Anti-TB drugs were administered immediately after
diagnosis of TB with a median 1 (0–20) day delay after
ICU admission. Mycobacterium tuberculosis complex was
isolated from all patients whose culture specimens were
positive. Among all patients, the susceptibility tests
showed rifampin resistance in 1 patient and isoniazid plus
streptomycin resistance in 1 patient.
Seven (43.8%) patients died in the ICU. One patient
died due to respiratory failure in hospital after being
discharged from the ICU. The cause of mortality in the
ICU was septic shock in 5 patients and respiratory failure
in 2 patients. Two of the 4 TB meningitis with pulmonary
tuberculosis patients died during the ICU stay. The median
ICU stay for all patients was 10.5 (5–122) days. The median
duration of hospitalization was 41 (6–122) days.
The patients who survived and did not survive in the
ICU are compared in Table 2. APACHE II and SOFA
scores were higher in patients who died (P = 0.012 and
0.048, respectively). At ICU admission the platelet and
albumin levels were lower in patients who died (P = 0.050
and 0.017, respectively). Six of the immunosuppressed
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16
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22
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9

18

6

18
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17

APACHE
II

No

Hypertension,
Heart failure
COPD

Pulmonary +
extrapulmonary
(lymphadenopathy)

Miliary

No

No

Diabetes
mellitus

Pleural

Heart failure

Yes

Renal
transplant

Pulmonary

Yes

Behçet’s
disease

Pulmonary+
extrapulmonary
(CNS)

Yes

Yes

RA

No

Pulmonary +
extrapulmonary
(CNS)

No

Yes

Yes

No

Miliary

No

HIV+

ALL

Miliary

Miliary

Miliary

No

Pulmonary+
extrapulmonary
(intestine)

No

TOF
(underwent
operation)
Yes

Yes

CRF
amyloidosis

HIV+

No

No

Immunosuppression

No

No

Comorbidity

Miliary

Pulmonary

Pulmonary

Extrapulmonary (CNS)

Extrapulmonary (CNS)

Form of TB

10

Neurological
deterioration
Sepsis

No
Acinetobacter spp.
(VAP)

No

No

72

7

Neurological
deterioration

Respiratory
failure
Respiratory
failure

45

Respiratory
failure

St.maltophilia
(VAP)
No

40

Neurological
deterioration

10

24

90

25

50

45

Cryptococcus
(meningitis)

Sepsis

Acinetobacter
(VAP)

Respiratory
failure

Acinetobacter
(VAP)
Neurological
deterioration

Sepsis

Pseudomonas
(VAP)

Candida
(meningitis)

Sepsis

Klebsiella
(bacteremia)

7

30

Respiratory
Failure
Sepsis

45

Hemoptysis

No

No

No

45

30

Neurological
deterioration

No

Time from
symptoms to
treatment (days)

Reason for
ICU
admission

Nasocomial
İnfection or
co-infection

1

2

20

4

3

0

3

0

0

15

4

0

1

0

0

0

Treatment
delay in
ICU (days)

No

No

No

NA

No

RIF

No

No

INH+SM

NA

NA

No

NA

NA

No

No

Anti-TB
drug
resistance*

Discharged

Leptomeningeal
(meningoencephalitis)

Exitus

Discharged

Exitus

Exitus

Exitus

Exitus

Disseminated
nodulary
Disseminated
nodulary
Left upper lobe posterior consolidation
Multiple cerebral,
cerebellar lesion
Leptomeningeal
Disseminated
bilateral nodulary
Cerebral
enfarct-edema
Left upper lobe nodule cavitary
Bilateral upper and lower
lobe consolidation

Bilateral nodulary

Bilateral nodulary
infiltration, cavitary,
Lymphadenopathy

Discharged

Discharged

Discharged

Exitus

Multiple micronodulary

Bilateral pleural effusion
Focal consolidation

Discharged

Discharged

Disseminated
nodulary
Nodulary

Discharged

Right upper lobe
cavity and nodulary

Exitus

Discharged

Leptomeningeal
(meningoencephalitis)

Left lower lobe cavity

Outcomes
in ICU

Radiological
interpretation

* Anti-TB drug resistance of patients whose diagnoses were based on biopsy proven granuloma consistent with TB and the results that were not found in medical records are shown as not available (NA).
Abbreviations; ALL: Acute Lymphoblastic leukemia, CNS: Central nervous system, COPD: Chronic obstructive pulmonary disease, CRF: Chronic renal failure, CSF: Cerebrospinal fluid, HIV: Human immunodeficiency virus, INH: Isoniazid, NA: Not available, RA:
Rheumatoid arthritis, RIF: Rifampicin, SM: Streptomycin, St. maltophilia: Stenotrophomonas maltophilia, TOF: Tetralogy of Fallot, VAP: Ventilator associated pneumonia

Age
(years)

Patient
no.

Table 1. Clinical features of active TB patients admitted to the ICU.
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Table 2. Comparison of patients who survived and did not survive.
Total
n = 16

Nonsurvivor
n=7

Survivor
n=9

P value

Age

45 (24–74)

47 (26–62)

40 (24–74)

0.832

Sex (male/female)

9/7

3/4

6/3

0.615

APACHE II

21.5 (6–36)

27 (18–36)

17 (6–29)

0.012

SOFA

6 (1–12)

9 (4–12)

4 (1–9)

0.048

GCS

11 (3–15)

11 (3–15)

12 (6–15)

0.389

Hemoglobin (g/dL)

10.6 (8.0–15.6)

9.1 (8.0–12.2)

12.1 (8.3–15.6)

0.071

Leukocytes (/µL) ×103

7.85 (0.3–16)

4.1 (0.3–16)

8.3 (4.9–13.4)

0.421

Platelets (/µL) ×103

158,5 (26–398)

101 (26–216)

236 (76–398)

0.050

Albumin (g/dL)

2.55 (1.22–4.40)

1.90 (1.22–2.81)

3.20 (1.69–4.40)

0.017

Hypoalbuminemia (<3.0 g/dL) yes/no (%)

9/7 (56)

7/0 (100)

2/7 (22)

0.003

C-reactive protein (mg/L)

7.01 (0.8–42)

13.5 (2.16–42)

5.25 (0.8–16.5)

0.153

Erythrocyte sedimentation rate (mm/h)

27 (3–78)

42.5 (5–78)

19 (3–71)

0.317

Immunosuppression yes/no (%)

8/8 (50)

6/1 (85)

2/7 (22)

0.041

Nosocomial infections yes/no (%)

8/8 (50)

7/0 (100)

1/8 (11)

0.010

Invasive mechanical ventilation yes/no (%)

10/6 (62.5)

7/0 (100)

3/6 (33)

0.011

Noninvasive mechanical ventilation n (%)

2 (12.5)

0 (0)

2 (22)

Duration on mechanical ventilation (day)

7 (3–45)

11 (5–45)

4.5 (3–7)

0.036

6/1 (85)

7/2 (77)

0.600

Acid resistant staining and/or TB culture +/− (%) 13/3 (75)
Time from symptoms to treatment (day)

35 (7–90)

45 (10–90)

30 (7–72)

0.240

Treatment delay in ICU (day)

1 (0–20)

3 (0–15)

1 (0–20)

0.658

Length of stay in ICU (day)

10.5 (5–122)

14 (6–50)

9 (5–122)

0.491

Length of stay in hospital (day)

41 (6–122)

42 (6–60)

40 (17–122)

0.277

Data are presented as number of cases (%) and median (minimum–maximum).

patients and 1 of the nonimmunosuppressed patients died
(P = 0.041). Seven of the 8 patients with nosocomial and/
or coinfection died. Conversely, all of the patients without
nosocomial infection and/or coinfection survived (P =
0.01). Seven (62.5%) of the 10 patients who underwent
invasive MV died (P = 0.011). The median MV duration
was 11 (5–45) days in patients who died and 4.5 (3–7) days
in patients who survived (P = 0.036). The median time
from symptom onset to treatment was 45 (10–90) days
in patients who died and 30 (7–72) days in patients who
survived. The median duration from ICU admission until
initiation of treatment was 3 (0–15) days in patients who
died and 1 (0–20) day in patients who survived.

4. Discussion
In this study, the clinical features of 16 newly diagnosed
active TB patients admitted to our ICU were evaluated.
Although TB is a treatable and curable disease, the mortality
rate in active TB patients requiring ICU admission is
high. The mortality rate of active TB patients with acute
respiratory failure requiring mechanical ventilation (MV)
ranges between 17.5% and 81% (2,5–8). It is more than
twice that of respiratory failure due to community-acquired
pneumonia (13). Another acute form of TB is meningitis,
which is the most severe form of extrapulmonary TB. Its
mortality rate ranges between 17% and 27% in Turkey
(14,15). Two of the 4 TB meningoencephalitis patients that
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had pulmonary tuberculosis died during ICU stay in our
study.
Frame et al. (5) reported a mortality rate of 67% for 43
active TB patients requiring ICU admission. The mortality
rate was 81% in the patients with acute respiratory failure
in this study. Erbes et al. (8) found a mortality rate of
22.4% for 58 TB patients requiring ICU admission, and the
number of patients who underwent MV was 22 (37.9%).
Ten (62.5%) patients received MV in our study. Seven
(43.8%) of these patients died in the ICU. The median MV
duration was longer in patients who died (11 (5–45) days)
than in patients who survived (1.5 (0–7) days).
Zahar et al. (10) found a 30-day mortality rate of 26.2%
for 99 TB patients with acute respiratory failure. The HIV
infection rate was 38.4% in these 99 TB patients with
acute respiratory failure. A time from symptom onset to
treatment of more than 1 month, the number of organ
failures, serum albumin level above 20 g/L, and the number
of lobes involved on chest X-ray were found as predictors
of mortality. Our study is a single center study with very
small sample size. Thus, it is limited in detecting the
independent factors associated with mortality. However,
lower platelet and albumin levels and higher SOFA scores
were observed in the patients who died compared with the
patients who survived in our study.
Sepsis, nosocomial pneumonia, and a requirement of
MV were associated with mortality in patients with active
tuberculosis (8). Four of the 7 patients who died had severe
pneumonia among our patients. Ryu et al. (11) found a 30day mortality rate of 59% for active TB patients requiring
ICU admission. Destroyed lung, APACHE II score above
20, and sepsis were found as predictors of mortality in that
study (11). In our study, APACHE II score for the patients
who died was significantly higher than for the patients who
survived (median 27 (18–36) and 17 (6–29), respectively).

Diseases or drugs that cause immunosuppression are
among the factors that increase mortality in patients with
active tuberculosis requiring ICU admission (9). In our
study, 8 patients had immunosuppression due to drugs or
diseases. Six of these patients died.
TB can, rarely, lead to sepsis or septic shock, which is
known as Landouzy septicemia (1,16,17). This process is
usually seen in immunocompromised patients, but may
be seen in immunocompetent patients (1,16,17). However,
other causal microorganisms must be excluded for the
diagnosis of TB-associated sepsis or septic shock. In our
study, other non-TB microorganisms were isolated from
blood and other body fluids in patients with septic shock.
Delayed treatment is another important factor that
contributes to mortality in active TB patients with acute
respiratory failure (10). Levy et al. (18) found 3–4 days of
treatment delay in hospital and a mortality rate of 33%
for TB patients with acute respiratory failure. The median
delay of anti-TB treatment was detected as 1 (0–20) day in
TB patients admitted to our ICU in this study. The median
time from symptom onset to treatment was 35 (7–90)
days. However, treatment delay in ICU and the time from
symptom onset to treatment was not found to be associated
with mortality in our study with a small sample size.
In conclusion, active TB patients admitted to the
ICU have higher mortality rates, especially patients with
immunosuppression, nosocomial and/or co-infection,
high APACHE II and SOFA scores, and patients receiving
mechanical ventilation. The mortality rate of patients
admitted to the ICU with acute presentation of TB was
higher than that of patients with chronic presentation of
the disease. Diagnostic tests should be conducted without
delay and treatment should be initiated early in patients
who are suspected of having tuberculosis.
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